The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making
This has further strengthened its manufacturing presence in the United States of America
The acquisition of myPOLS Biotec complements Medix Biochemica’s leading portfolio of IVD raw materials and expands its reagent offerings for molecular diagnostics
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
Subscribe To Our Newsletter & Stay Updated
